【SUNZEN 0148 交流专区】宏诚生科

icy97

EX-date	06/05/2014
Entitlement date	08/05/2014
Entitlement time	05:00:00 PM
Entitlement subject	Interim Dividend
Entitlement description	A single-tier interim dividend of RM0.008 per ordinary share of RM0.10 each in respect of the financial year ending 31 December 2014
Period of interest payment	to
Financial Year End
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Symphony Share Registrars Sdn Bhd Level 6 Symphony House Block D13, Pusat Dagangan Dana 1 Jalan PJU 1A/46 47301 Petaling Jaya Selangor Darul Ehsan Tel: 603.7841.8000
Payment date	22/05/2014
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	08/05/2014
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.008

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/03/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/03/2014	31/03/2013	31/03/2014	31/03/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	8,435	8,174	8,435	8,174
2	Profit/(loss) before tax	381	797	381	797
3	Profit/(loss) for the period	261	668	261	668
4	Profit/(loss) attributable to ordinary equity holders of the parent	261	668	261	668
5	Basic earnings/(loss) per share (Subunit)	0.17	0.45	0.17	0.45
6	Proposed/Declared dividend per share (Subunit)	0.80	0.00	0.80	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2200		0.2200

icy97

Notice of Person Ceasing (29C)

SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder

Name	Fong Chan Seng
Address	12 Jalan USJ 5/4C 47610 Subang Jaya Selangor Darul Ehsan
NRIC/Passport No/Company No.	470905-02-5365
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Date of cessation	09/07/2014
Name & address of registered holder	Fong Chan Seng 12 Jalan USJ 5/4C 47610 Subang Jaya Selangor Darul Ehsan
Currency	Malaysian Ringgit (MYR)
Number of securities disposed	10,436,000
Price Transacted ($$)
Circumstances by reason of which a person ceases to be a substantial securities Holder	Disposal of Shares
Nature of interest	Direct
Date of notice	10/07/2014

icy97

Notice of Person Ceasing (29C)

SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder

Name	Teo Kim Lai
Address	168-9-5 Kiara Park Condominium Jalan Burhanuddin Helmi Taman Tun Dr Ismail 60000 Kuala Lumpur Wilayah Persekutuan
NRIC/Passport No/Company No.	630103-01-5413
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Date of cessation	10/07/2014
Name & address of registered holder	Teo Kim Lai 168-9-5 Kiara Park Condominium Jalan Burhanuddin Helmi Taman Tun Dr Ismail 60000 Kuala Lumpur Wilayah Persekutuan
Currency	Malaysian Ringgit (MYR)
Number of securities disposed	4,200,000
Price Transacted ($$)
Circumstances by reason of which a person ceases to be a substantial securities Holder	Disposal of shares via married deal
Nature of interest	Direct
Date of notice	11/07/2014

icy97

Date of change	14/07/2014
Name	Hong Choon Hau
Age	37
Nationality	Malaysian
Type of change	Redesignation
Previous Position	Non-Executive Director
New Position	Non-Executive Director
Directorate	Non Independent & Non Executive
Qualifications	Diploma in Computer Science/Information Technology
Working experience and occupation	2011 -2012 - Executive Director of MBI Mobile Marketing 2012 - 2013 - Executive Director of Gameview Sdn Bhd 2013 - Current - Director of Play4fun Sdn Bhd 2014 - Current - Group Executive Director/Financial Controller of Myworld Holdings Berhad
Directorship of public companies (if any)	Myworld Holdings Berhad
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Mr Hong holds 41,046,000 ordinary shares and 12,000,000 warrants in the Company

icy97

宏诚生科27.5%场外易手

财经新闻 财经  2014-07-16 08:14
（吉隆坡15日讯）宏诚生科（SUNZEN，0148，创业板）共有4105万股，或27.5%股权在场外易手，每股作价26仙，总值1067万令吉。

相比昨日的闭市价37仙，也是历史闭市新高，这批场外交易的股票折价29.73%。

该股是在32.5仙至38.5仙区间交易，成交量有987万3800股。

宏诚生科WA也有场外交易，在公开市场也交投活络。

共有1660万凭单在场外易手，每张16仙，总值约266万令吉。

宏诚生科WA昨日则收于29仙，扬5.5仙，或23.4%，成交量有480万4700张。

最近，公司一些董事在脱售持股权。单是7月，执行董事方晨成（译音）售出1044万股，持股权从11.01%，降至4.02%。

另一名执行董事郭培楚（译音）也将持股权，从12.7%，减至上周五的8.84%。

宏诚生科截至12月的2013财年净利大涨149%，报351万令吉，上财年为142万令吉。营业额则扬13.81%，达3733万令吉。【南洋网财经】

icy97

Notice of Person Ceasing (29C)

SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder

Name	Tan Kim Sing
Address	16 Jalan SS 18/1A 47500 Subang Jaya Selangor Darul Ehsan
NRIC/Passport No/Company No.	490805-02-5075
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Date of cessation	14/07/2014
Name & address of registered holder	Tan Kim Sing 16 Jalan SS 18/1A 47500 Subang Jaya Selangor Darul Ehsan
Currency	Malaysian Ringgit (MYR)
Number of securities disposed	41,046,000
Price Transacted ($$)
Circumstances by reason of which a person ceases to be a substantial securities Holder	Disposal of shares
Nature of interest	Direct
Date of notice	16/07/2014

Notice of Interest Sub. S-hldr (29A)
Particulars of Substantial Securities Holder

Name	Hong Choon Hau
Address	10, Jalan Margosa SD10/4C Bandar Sri Damansara 52200 Kuala Lumpur
NRIC/Passport No/Company No.	761113-02-5869
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Name & address of registered holder	Hong Choon Hau 10, Jalan Margosa SD10/4C Bandar Sri Damansara 52200 Kuala Lumpur

Date interest acquired & no of securities acquired
Currency	Malaysian Ringgit (MYR)
Date interest acquired	14/07/2014
No of securities	41,046,000
Circumstances by reason of which Securities Holder has interest	Acquisition of shares
Nature of interest	Direct
Price Transacted ($$)
Total no of securities after change
Direct (units)	41,046,000
Direct (%)	27.5
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Date of notice	16/07/2014

icy97

Name	Teo Kim Lai
Address	168-9-5 Kiara Park Condominium Jalan Burhanuddin Helmi Taman Tun Dr Ismail 60000 Kuala Lumpur Wilayah Persekutuan
Descriptions(Class & nominal value)	Ordinary Shares of RM0.10 each

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction	Date of change	No of securities	Price Transacted (RM)
Disposed	16/07/2014	4,259,000	0.260

Circumstances by reason of which change has occurred	Disposal of shares via married deal
Nature of interest	Direct
Consideration (if any)

Total no of securities after change
Direct (units)	1,179,060
Direct (%)	0.79
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Date of notice	17/07/2014

Name	Fong Chan Seng
Address	12, Jalan USJ 5/4C 47610 Subang Jaya Selangor Darul Ehsan
Descriptions(Class & nominal value)	Ordinary Shares of RM0.10 each

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction	Date of change	No of securities	Price Transacted (RM)
Disposed	16/07/2014	2,000,000	0.260

Circumstances by reason of which change has occurred	Disposal of shares
Nature of interest	Direct
Consideration (if any)

Total no of securities after change
Direct (units)	4,000,860
Direct (%)	2.68
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Date of notice	17/07/2014

icy97

Date of change	17/07/2014
Name	Teo Kim Lai
Age	51
Nationality	Malaysian
Designation	Executive Director
Directorate	Executive
Type of change	Resignation
Reason	Personal reason
Details of any disagreement that he/she has with the Board of Directors	No
Whether there are any matters that need to be brought to the attention of the shareholders	No
Qualifications	Professional Degree of Doctor of Veterinary Medicine from Universiti Putra Malaysia
Working experience and occupation	Prior to joining Sunzen Corporation Sdn. Bhd. (“Sunzen Corporation”), Dr. Teo Kim Lai held the position of field veterinarian in Federal Flour Mill Berhad from 1989 to 1990, Operational Manager in Oriental Feedmill, which under the wings of Robert Kuok’s Group in Lioaning, China from 1991 to 1992, Poultry Team Leader in Pfizer from 1993 to 1994, General Manager in Mallinckrodt Inc of China and Hong Kong in 1995, and General Team Leader and National Sales Manager in Pfizer from 1996 to 1998. In 1998, Dr. Teo together with the existing management of Pfizer in Malaysia, established Sunzen Corporation to undertake a management buy-out of Pfizer’s local distribution and marketing operations. Dr. Teo was then appointed as a Director of Sunzen Corporation since its inception. Dr. Teo was the Vice President of the Malaysia Association of Food Animal from 2000 to 2001 and the Vice President of the Veterinary Alumni of UPM from 2003 to 2004. Dr.Teo was also a volunteer veterinary officer of the National Virus Eradication Campaign of the Department of Veterinary Services of the Ministry of Agriculture in 1999 and later became an adviser on the Technical Advisory Committee of Federation of Farmers Association Malaysia in 2000. Dr. Teo is currently an Honorary Secretary of World Poultry Science Association Malaysia Branch since 2008. He was the Honorary Secretary of Malaysia Iran Business Council from 2009 to 2010.
Directorship of public companies (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Dr. Teo holds 1,179,060 ordinary shares and 192,686 warrants in the Company

icy97

icy97 发表于 17-7-2014 02:17 AM
Notice of Person Ceasing (29C)
Particulars of substantial Securities Holder

宏诚生科新董事 持27.5%最大股东

财经新闻 财经  2014-07-19 12:30
（吉隆坡18日讯）宏诚生科（SUNZEN，0148，创业板）最近委任的非独立非执行董事洪俊豪（译音），崛起成为最大单一股东，持股27.5%。

宏诚生科向大马交易所报备，洪俊豪在本周一购入4105万股，相等于27.5%股权。

同日，主席兼董事经理陈健生脱售同等数额的股票，不再是公司大股东。

此外，洪俊豪以每张16仙，认购1200万凭单，持有权为24.12%。

周一，共有4105万股，每股作价26仙，以及1660万凭单，每张16仙，在场外易手。【南洋网财经】

icy97

Date of change	18/07/2014
Name	Fong Chan Seng
Age	66
Nationality	Malaysian
Designation	Executive Director
Directorate	Executive
Type of change	Resignation
Reason	Personal reason
Details of any disagreement that he/she has with the Board of Directors	No
Whether there are any matters that need to be brought to the attention of the shareholders	No
Qualifications	Bachelor of Veterinary Science and Animal Husbandry degree from Bombay Veterinary College, India.
Working experience and occupation	Dr. Fong Chan Seng has thirty seven (37) years of industry experience. He held several job portfolios during his employment with Pfizer - Malaysia. Dr. Fong joined Pfizer as Veterinary Promotions Manager in 1981. Throughout seven (7) years of serving the domestic market in Malaysia, he held positions as Product Manager, National Sales Manager and Feedmill Marketing Manager. Dr. Fong was posted to Thailand as the Business Manager of Pfizer Thailand Ltd for three (3) years from 1988 to 1990. He was promoted to the position of Regional Director of Sales for Association of South East Asia Nation (“ASEAN”) countries in 1991. In 1998, Dr. Fong together with the existing management of Pfizer in Malaysia, established Sunzen Corporation Sdn. Bhd. (“Sunzen Corporation”) to undertake a management buy-out of Pfizer’s local distribution and marketing operations. In 2001, Dr. Fong left Sunzen Corporation to join Phibro Animal Health Inc, USA as Regional Director for ASEAN countries and as Managing Director of their local incorporated company, Phibro Malaysia Sdn Bhd. He rejoined Sunzen Corporation in 2002.
Directorship of public companies (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Dr. Fong holds 4,000,860 shares and 953 warrants in the Company

icy97

宏诚生科主席呈辞 新大股东任CEO

财经新闻 财经  2014-07-23 11:34
（吉隆坡22日讯）宏诚生科（SUNZEN，0148，创业板）主席兼董事经理陈健生以私人原因为由，辞去职务。

早前崛起成为单一大股东的洪俊豪（译音），受委任成为总执行长，他之前是非独立非执行董事。

洪俊豪于公司持有4104万6000股，以及1200万凭单，同时也是Myworld控股执行董事兼财务总监。

同为独立非执行董事的林英才（译音），受委任为公司执行董事兼总营运长，任期由今日起生效。

林英才也是Ninetology（南区）有限公司总营运长，他于宏诚生科持有600万股，以及200万凭单。

宏诚生科非执行董事S古纳瑟哈然，也以私人原因为由辞职。【南洋网财经】

Date of change	21/07/2014
Name	Hong Choon Hau
Age	37
Nationality	Malaysian
Type of change	Redesignation
Previous Position	Non-Executive Director
New Position	Chief Executive Officer
Directorate	Executive
Qualifications	Diploma in Computer Science/Information Technology
Working experience and occupation	2011 -2012 - Executive Director of MBI Mobile Marketing 2012 - 2013 - Executive Director of Gameview Sdn Bhd 2013 - Current - Director of Play4fun Sdn Bhd 2014 - Current - Group Executive Director/Financial Controller of Myworld Holdings Berhad
Directorship of public companies (if any)	Myworld Holdings Berhad
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Mr Hong holds 41,046,000 ordinary shares and 12,000,000 warrants in the Company

Date of change	21/07/2014
Name	Tan Kim Sing
Age	64
Nationality	Malaysian
Designation	Chairman & Managing Director
Directorate	Executive
Type of change	Resignation
Reason	Personal reason
Details of any disagreement that he/she has with the Board of Directors	No
Whether there are any matters that need to be brought to the attention of the shareholders	No
Qualifications	- Bachelor of Veterinary Science and Animal Husbandry from Bombay Veterinary College in India (1975) - Master of Philosophy in Veterinary Science from Massey University, New Zealand (1979)
Working experience and occupation	Dr. Tan Kim Sing has thirty five (35) years of experience in animal health industry, mainly involved in management, sales, marketing and technical services. Prior to forming Sunzen Corporation Sdn. Bhd. (“Sunzen Corporation”), he spent about twenty one (21) years with Pfizer. He started as Technical Manager in 1979 before becoming a Sales Manager, Product Manager, Premix Manager and Division Director. In 1998, Dr. Tan has together with the existing management of Pfizer in Malaysia, established Sunzen Corporation to undertake a management buy out of Pfizer’s local distribution and marketing operations. He was then appointed as the Managing Director of Sunzen Corporation since its inception. Dr. Tan is currently the Vice President of the Malaysian Animal Health & Nutrition Industries Association and a member of the Malaysian Veterinary Council.
Directorship of public companies (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Dr. Tan holds 510 shares and 169 warrants in the Company

ate of change	21/07/2014
Name	Lim Eng Chai
Age	43
Nationality	Malaysian
Type of change	Redesignation
Previous Position	Non-Executive Director
New Position	Chief Operating Officer
Directorate	Executive
Qualifications	Diploma in Art & Design
Working experience and occupation	2014 - Current - Chief Operating Officer of Ninetology (Southern) Sdn Bhd 2004 - Current - Director of Excelcity Hi- Tech Sdn Bhd 2012 - Current - Director of BP Excelcity Sdn Bhd(Celcom exclusive Partner -Kluang) 2012 - Current - Director of Angsana Edar Sdn Bhd (TM Point Parit Raja) 2012 - Current - Director of Angsana Venture Sdn Bhd (TM Point Batu Pahat Mall)
Directorship of public companies (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Mr. Lim holds 6,000,000 shares and 2,000,000 warrants in the Company

icy97

Date of change	21/07/2014
Name	Tan Sri Haji Musa Bin Tan Sri Haji Hassan
Age	62
Nationality	Malaysian
Type of change	Appointment
Designation	Chairman
Directorate	Independent & Non Executive
Qualifications	- School Certificate and Malaysian Certificate of Education 1968 - Diploma In Law, University College of Wales Aberystwyth UK 1985 - Ijazah Kehormat Doktor Falsafah (Pengurusan Teknologi) 2010 - Advanced Management Program Templeton College University Oxford UK 2002
Working experience and occupation	- Investigation & Prosecution Officer in Malacca - 1970–1973 - Investigation Officer & Area Inspector Alor Gajah Malacca -1973-1975 - Intell and Ops Officer Drug Enforcement Branch Bkt Aman -1975-1986 - Law Lecturer and Head of Law School at Police College – 1986-1991 - Head of Police Law Examination Syndicate – 1991-1995 - Head of Legal Section CID – 1995-2000 - Deputy Director CID II – 2000-2001 - Deputy Director CID I – 2001-2003 - Chief Police Officer of Johore – 2003-2004 - Director of Criminal Investigation Dept. – 2004 - Deputy Inspector General of Police – 2005-2006 - Inspector General of Police – 2006-2010
Directorship of public companies (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Tan Sri Haji Musa Bin Tan Sri Haji Hassan holds 2,000,000 shares and 650,000 warrants in the Company.

icy97

Notice of Person Ceasing (29C)

SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder

Name	Kok Poe Chu
Address	25 Jalan USJ 3/4N 47600 UEP Subang Jaya Selangor Darul Ehsan
NRIC/Passport No/Company No.	610412-02-5473
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Date of cessation	21/07/2014
Name & address of registered holder	Kok Poe Chu 25 Jalan USJ 3/4N 47600 UEP Subang Jaya Selangor Darul Ehsan
Currency	Malaysian Ringgit (MYR)
Number of securities disposed	4,780,000
Price Transacted ($$)
Circumstances by reason of which a person ceases to be a substantial securities Holder	Disposal of shares
Nature of interest	Direct
Date of notice	22/07/2014

云如水

换了新董事，现在的价位能买吗

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/06/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/06/2014	30/06/2013	30/06/2014	30/06/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	9,886	8,553	18,321	16,727
2	Profit/(loss) before tax	317	770	698	1,567
3	Profit/(loss) for the period	283	645	544	1,313
4	Profit/(loss) attributable to ordinary equity holders of the parent	283	645	544	1,313
5	Basic earnings/(loss) per share (Subunit)	0.19	0.43	0.36	0.88
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2100		0.2200

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD (“SUNZEN” OR “COMPANY”) – DISTRIBUTION AGREEMENT BETWEEN SUNZEN CORPORATION SDN BHD AND ZOETIS MALAYSIA SDN BHD
Reference is made to the Distribution Agreement made between Sunzen Corporation Sdn. Bhd. (“Sunzen Corporation”), a wholly-owned subsidiary of the Company and Zoetis Malaysia Sdn. Bhd. (“Zoetis”) dated 1 May 2011 as a result of the Novation Agreement dated 18 September 2012 and its extension (“Distribution Agreement”). Pursuant to Rule 9.04(b) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of Sunzen wishes to announce that Zoetis had, on 3 October 2014, pursuant to the terms of the Distribution Agreement, served a notice to Sunzen Corporation, to confirm that the Distribution Agreement will expire on 31 December 2014 and both parties shall then immediately enter into good faith negotiations so as to establish the a contractual relationship. As advised by Zoetis, the expiration of the Distribution Agreement and the mutual intention of re-establishing the new contractual relationship are made in order to align with the change of Zoetis Business Model. Zoetis will manage the companion animal portfolio while, upon the conclusion of the new contractual relationship, Sunzen Corporation is expected to enter into a 3-year non-exclusive distribution agreement for its products and then become Zoetis’ key swine portfolio partner. There were no significant events leading to the service of the aforesaid notice of expiration of the Distribution Agreement by Zoetis. Zoetis had served the said notice of expiration pursuant to Clause 5 of the Distribution Agreement which provides that Zoetis may terminate the Distribution Agreement. Zoetis is a major supplier of animal vaccines, veterinary pharmaceuticals and antibiotic feed additives for the Sunzen Group. Based on the audited consolidated financial statements of Sunzen for the financial year ended 31 December 2013, the Sunzen Group recorded a total revenue of RM37,325,958 of which Zoetis’ sales contributed RM6,595,452 or approximately 17% of its Group’s revenue. There will be no operational impact to Sunzen Group as the manpower will be mobilised for other existing contracts for the supply of animal vaccines, veterinary pharmaceuticals and antibiotics feed additives to the customers. The Board of Directors is of the view that the Sunzen Group’s future revenue and profitability may be affected due to the termination of the above Distribution Agreement and the Group’s revenue and probability may recover subsequently once the new distribution agreement is finalised. This announcement is dated 8 October 2014.

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	SUNZEN BIOTECH BERHAD (“SUNZEN” OR “COMPANY”) PROPOSED PRIVATE PLACEMENT OF NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN, REPRESENTING NOT MORE THAN TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF SUNZEN (EXCLUDING TREASURY SHARES) (“PROPOSED PRIVATE PLACEMENT”)
On behalf of the Board of Directors of Sunzen, TA Securities Holdings Berhad wishes to announce that the Company proposes to undertake the Proposed Private Placement. Please refer to the attachment for further details of the announcement. This announcement is dated 17 October 2014. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1768733

Attachments Sunzen - Announcement - Proposed Private Placement (132D).pdf

APULA

私配1990万股 宏诚股冀筹696万
财经新闻 财经  2014-10-19 11:12
http://www.nanyang.com/node/656758

（吉隆坡18日讯）宏诚生科（SUNZEN，0148，创业板）建议发售最多1990万2000私下配售股，筹资最高696万6000令吉。

文告显示，将在稍后公布发售价，以及上述私配股的发售对象。

假设定价是每股35仙，则可最多筹得696万6000令吉。

公司计划把当中的675万6000令吉，用于提升和添购厂房和机械，余额则是该企业活动的成本。

icy97

ype	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	SUNZEN BIOTECH BERHAD (“SUNZEN” OR “COMPANY”) PROPOSED PRIVATE PLACEMENT OF NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN, REPRESENTING NOT MORE THAN TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF SUNZEN (EXCLUDING TREASURY SHARES) (“PROPOSED PRIVATE PLACEMENT”)
We refer to the announcement made on 17 October 2014 (“Announcement”) in relation to the Proposed Private Placement and wish to provide the following additional information. Unless otherwise defined, the definitions set out in the Announcement shall apply herein. As stated in Note (1) in Section 2.6 of the Announcement, with the additional production lines, the Sunzen Group is expected to increase the current production capacity of its pilot plant of approximately 50kg of Orgacids-AQUA per hour to approximately 1,000kg of Orgacids-AQUA and Powder Fat per hour, which will facilitate the Group to produce and commercialise the abovementioned new complementary products. The Sunzen Group is currently in discussion with several potential customers for the supply of Orgacids-AQUA and Powder Fat. However, no contract and order has been secured as at 17 October 2014 and the Sunzen Group expects to finalise the discussion in 2015. The Sunzen Group is also in the midst of promoting the said new complementary products via marketing activities. For instance, the Sunzen Group had together with its collaborators at Universiti Sains Malaysia disclosed the scientific findings of the said new complementary products at various local and international platforms which include Malaysia Agriculture, Horticulture and Agrotourism Show 2012 in Malaysia, Aquafeed Horizons Asia 2014 in Bangkok, Thailand and 16th International Symposium on Fish Nutrition and Feeding in Cairns, Australia. This announcement is dated 21 October 2014.